ROSEN, A LONGSTANDING LAW FIRM, Encourages TriplePoint Venture Growth BDC Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TPVG

NEW YORK, June 29, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TriplePoint Venture Growth BDC Corp. (NYSE: TPVG) between March 4, 2020 and May 1, 2023, both dates inclusive (the “Class Period”), of the important August 15, 2023 lead plaintiff deadline. SO WHAT: […]

NEW YORK, June 29, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TriplePoint Venture Growth BDC Corp. (NYSE: TPVG) between March 4, 2020 and May 1, 2023, both dates inclusive (the “Class Period”), of the important August 15, 2023 lead plaintiff deadline.

SO WHAT: If you purchased TriplePoint securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the TriplePoint class action, go to https://rosenlegal.com/submit-form/?case_id=15759 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 15, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants made false and/or misleading statements regarding the Company’s business, operations, and prospects. Specifically, defendants failed to disclose to investors that: (1) TriplePoint had overstated the strength of its various portfolio companies and loan book, as well as the viability of its overall investment strategy; (2) the foregoing, once revealed, was likely to have a material negative impact on the Company’s financial position and/or prospects; and (3) as a result, the Company’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the TriplePoint class action, go to https://rosenlegal.com/submit-form/?case_id=15759 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8867099

Previous Article

St Kitts and Nevis announces extension to Citizenship by Investment Programme Sustainable Growth Fund Limited Time Offer due to unprecedented demand

Next Article

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages UP Fintech Holding Limited Investors to Secure Counsel Before Important Deadline in First Filed Securities Class Action Commenced by the Firm – TIGR

Related Posts

With increasing R&D investment, GWM discloses Over 6,000 Patents

BAODING, China, Feb. 16, 2023 /PRNewswire/ — Recently, the 2022 list released by AutoPat, the global automotive patent big data platform, shows that GWM owned 6,042 patent disclosures and 4,652 patent authorizations, with a year-on-year increase of 62.86% and 42.87% respectively. Moreover, in the NEV field, GWM possessed 1,966 patent disclosures and 1,650 patent authorizations, […]

‫توقعت الأعمال التجارية عام 2022: رؤساء تنفيذيون عالميون يعربون عن تفاؤلهم

طوكيو، 15 ديسمبر 2021 /PRNewswire/ — تنبأ ما يزيد عن 80% من المديرين التنفيذيين العاملين في 44 قطاع على مستوى العالم باستمرار زخم النمو الاقتصادي الحالي خلال عام 2022، وذلك رغم ارتفاع مستوى عدم اليقين، حسبما أظهر أحد الاستبيانات التي أجرتها مؤخرًا منظمة الرؤساء الشباب YPO. شمل الاستبيان، الذي أجرته المنظمة في الفترة ما بين 18 […]

Nyxoah Announces CE-Mark Indication Approval to Treat Complete Concentric Collapse (CCC) Patients

INSIDE INFORMATION REGULATED INFORMATION Nyxoah Announces CE-Mark Indication Approval to Treat Complete Concentric Collapse (CCC) Patients Notified Body DEKRA approves IFU changes to remove warning regarding CCC patients Mont-Saint-Guibert, Belgium – October 4, 2021, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development […]

Nyxoah Issues First Half 2021 Financial Results

REGULATED INFORMATION Nyxoah Issues First Half 2021 Financial Results Mont-Saint-Guibert, Belgium – August 31, 2021, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced its unaudited condensed consolidated interim […]